Cargando…

Relation of Biochemical Parameters with Flow-mediated Dilatation in Patients with Metabolic Syndrome

BACKGROUND: Metabolic syndrome (MetS) is one of the high cardiovascular (CV) situations. Endothelial dysfunction, which is a common finding in patients with MetS, is related with increased CV risk. In patients with MetS, the effect of the major CV risk factors, not included in the MetS definition, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sipahioglu, Nurver Turfaner, Ilerigelen, Barıs, Gungor, Zeynep B., Ayaz, Gulsel, Ekmekci, Hakan, Gurel, Cigdem Bayram, Can, Gunay, Sonmez, Huseyin, Ulutin, Turgut, Sipahioglu, Fikret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494920/
https://www.ncbi.nlm.nih.gov/pubmed/28639572
http://dx.doi.org/10.4103/0366-6999.208231
_version_ 1783247742451056640
author Sipahioglu, Nurver Turfaner
Ilerigelen, Barıs
Gungor, Zeynep B.
Ayaz, Gulsel
Ekmekci, Hakan
Gurel, Cigdem Bayram
Can, Gunay
Sonmez, Huseyin
Ulutin, Turgut
Sipahioglu, Fikret
author_facet Sipahioglu, Nurver Turfaner
Ilerigelen, Barıs
Gungor, Zeynep B.
Ayaz, Gulsel
Ekmekci, Hakan
Gurel, Cigdem Bayram
Can, Gunay
Sonmez, Huseyin
Ulutin, Turgut
Sipahioglu, Fikret
author_sort Sipahioglu, Nurver Turfaner
collection PubMed
description BACKGROUND: Metabolic syndrome (MetS) is one of the high cardiovascular (CV) situations. Endothelial dysfunction, which is a common finding in patients with MetS, is related with increased CV risk. In patients with MetS, the effect of the major CV risk factors, not included in the MetS definition, on endothelial dysfunction is not well known. The aim of this study was to determine the effect of major CV risk factors such as gender, smoking, family history, and biochemical parameters on endothelial dysfunction in patients with MetS. METHODS: The study was performed between December 2010 and August 2014. A total of 55 patients (15 females and 40 males) with MetS and 81 healthy controls (37 females and 44 males) with a body mass index <25 kg/m(2) were enrolled in the study. Endothelial dysfunction was measured by flow-mediated dilatation (FMD), oxidative stress parameters; high-sensitivity C-reactive protein (hs-CRP), oxidized low-density lipoprotein (ox-LDL), endothelial nitric oxide synthase (e-NOS), nitric oxide, and cell adhesion markers; von Willebrand factor, and e-selectin. Platelet aggregation (endothelial adenosine diphosphate), total platelet count, and mean platelet volume were additionally analyzed and demographic parameters were explored. Student's t-test, Mann-Whitney U-test, and Chi-square test were used to analyze the results. RESULTS: The fasting blood glucose (z = 3.52, P = 0.001), hs-CRP (z = 3.23, P = 0.004), ox-LDL (z = 2.62, P = 0.013), and e-NOS (z = 2.22, P = 0.026) levels and cardiac risk score (z = 5.23, P < 0.001) were significantly higher in patients with MetS compared with the control group. Smoking was correlated with decreased FMD (χ(2) = 9.26, P = 0.002) in MetS patients but not in the control group. CONCLUSIONS: Increased ox-LDL, hs-CRP, and e-NOS are likely to be a result of oxidative stress, a condition in which an imbalance occurs between the production and inactivation of reactive nitrogen and oxygen species. In addition, in patients with MetS, smoking is independently related to endothelial dysfunction.
format Online
Article
Text
id pubmed-5494920
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-54949202017-07-14 Relation of Biochemical Parameters with Flow-mediated Dilatation in Patients with Metabolic Syndrome Sipahioglu, Nurver Turfaner Ilerigelen, Barıs Gungor, Zeynep B. Ayaz, Gulsel Ekmekci, Hakan Gurel, Cigdem Bayram Can, Gunay Sonmez, Huseyin Ulutin, Turgut Sipahioglu, Fikret Chin Med J (Engl) Original Article BACKGROUND: Metabolic syndrome (MetS) is one of the high cardiovascular (CV) situations. Endothelial dysfunction, which is a common finding in patients with MetS, is related with increased CV risk. In patients with MetS, the effect of the major CV risk factors, not included in the MetS definition, on endothelial dysfunction is not well known. The aim of this study was to determine the effect of major CV risk factors such as gender, smoking, family history, and biochemical parameters on endothelial dysfunction in patients with MetS. METHODS: The study was performed between December 2010 and August 2014. A total of 55 patients (15 females and 40 males) with MetS and 81 healthy controls (37 females and 44 males) with a body mass index <25 kg/m(2) were enrolled in the study. Endothelial dysfunction was measured by flow-mediated dilatation (FMD), oxidative stress parameters; high-sensitivity C-reactive protein (hs-CRP), oxidized low-density lipoprotein (ox-LDL), endothelial nitric oxide synthase (e-NOS), nitric oxide, and cell adhesion markers; von Willebrand factor, and e-selectin. Platelet aggregation (endothelial adenosine diphosphate), total platelet count, and mean platelet volume were additionally analyzed and demographic parameters were explored. Student's t-test, Mann-Whitney U-test, and Chi-square test were used to analyze the results. RESULTS: The fasting blood glucose (z = 3.52, P = 0.001), hs-CRP (z = 3.23, P = 0.004), ox-LDL (z = 2.62, P = 0.013), and e-NOS (z = 2.22, P = 0.026) levels and cardiac risk score (z = 5.23, P < 0.001) were significantly higher in patients with MetS compared with the control group. Smoking was correlated with decreased FMD (χ(2) = 9.26, P = 0.002) in MetS patients but not in the control group. CONCLUSIONS: Increased ox-LDL, hs-CRP, and e-NOS are likely to be a result of oxidative stress, a condition in which an imbalance occurs between the production and inactivation of reactive nitrogen and oxygen species. In addition, in patients with MetS, smoking is independently related to endothelial dysfunction. Medknow Publications & Media Pvt Ltd 2017-07-05 /pmc/articles/PMC5494920/ /pubmed/28639572 http://dx.doi.org/10.4103/0366-6999.208231 Text en Copyright: © 2017 Chinese Medical Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Sipahioglu, Nurver Turfaner
Ilerigelen, Barıs
Gungor, Zeynep B.
Ayaz, Gulsel
Ekmekci, Hakan
Gurel, Cigdem Bayram
Can, Gunay
Sonmez, Huseyin
Ulutin, Turgut
Sipahioglu, Fikret
Relation of Biochemical Parameters with Flow-mediated Dilatation in Patients with Metabolic Syndrome
title Relation of Biochemical Parameters with Flow-mediated Dilatation in Patients with Metabolic Syndrome
title_full Relation of Biochemical Parameters with Flow-mediated Dilatation in Patients with Metabolic Syndrome
title_fullStr Relation of Biochemical Parameters with Flow-mediated Dilatation in Patients with Metabolic Syndrome
title_full_unstemmed Relation of Biochemical Parameters with Flow-mediated Dilatation in Patients with Metabolic Syndrome
title_short Relation of Biochemical Parameters with Flow-mediated Dilatation in Patients with Metabolic Syndrome
title_sort relation of biochemical parameters with flow-mediated dilatation in patients with metabolic syndrome
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494920/
https://www.ncbi.nlm.nih.gov/pubmed/28639572
http://dx.doi.org/10.4103/0366-6999.208231
work_keys_str_mv AT sipahioglunurverturfaner relationofbiochemicalparameterswithflowmediateddilatationinpatientswithmetabolicsyndrome
AT ilerigelenbarıs relationofbiochemicalparameterswithflowmediateddilatationinpatientswithmetabolicsyndrome
AT gungorzeynepb relationofbiochemicalparameterswithflowmediateddilatationinpatientswithmetabolicsyndrome
AT ayazgulsel relationofbiochemicalparameterswithflowmediateddilatationinpatientswithmetabolicsyndrome
AT ekmekcihakan relationofbiochemicalparameterswithflowmediateddilatationinpatientswithmetabolicsyndrome
AT gurelcigdembayram relationofbiochemicalparameterswithflowmediateddilatationinpatientswithmetabolicsyndrome
AT cangunay relationofbiochemicalparameterswithflowmediateddilatationinpatientswithmetabolicsyndrome
AT sonmezhuseyin relationofbiochemicalparameterswithflowmediateddilatationinpatientswithmetabolicsyndrome
AT ulutinturgut relationofbiochemicalparameterswithflowmediateddilatationinpatientswithmetabolicsyndrome
AT sipahioglufikret relationofbiochemicalparameterswithflowmediateddilatationinpatientswithmetabolicsyndrome